Literature DB >> 25985011

Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction.

Gérard Helft1, Jean-Louis Georges2, Xavier Mouranche3, Aurélie Loyeau3, Christian Spaulding4, Christophe Caussin5, Hakim Benamer6, Philippe Garot7, Bernard Livarek2, Emmanuel Teiger8, Olivier Varenne9, Jacques Monségu5, Mireille Mapouata3, Thibaut Petroni10, Nadjib Hammoudi10, Yves Lambert11, François Dupas12, François Laborne13, Frederic Lapostolle14, Hugues Lefort15, Jean-Michel Juliard16, Jean-Yves Letarnec17, Lionel Lamhaut18, Gaëlle Lebail19, Thévy Boche20, Xavier Jouven4, Sophie Bataille3.   

Abstract

BACKGROUND: Few data are available on primary percutaneous coronary intervention (pPCI) in nonagenarians. In a large prospective registry on pPCI for STEMI we compared the demographics, procedural and in-hospital outcomes between nonagenarians (age ≥ 90 years) and patients aged < 90 years. METHODS AND
RESULTS: We included 26,157 consecutive patients with pPCI in the Greater Paris Area region between 2003 and 2011. Of these, 418 (1.6%) were ≥ 90 years old. Nonagenarians (versus patients < 90 years) were more likely to be female (62.3% versus 22.5%, p < 0.0001), nonsmokers (81.6% versus 36.7%, p < 0.0001), in cardiogenic shock (Killip IV) upon admission (10.5% versus 4.8%, p < 0.001), and had significant co-morbidities. Over two-thirds of patients underwent procedures via the radial artery (61% versus 72.1%, p = 0.007). Both groups had high and similar angiographic success rates (98.1% versus 98.7%, p = 0.33). Drug-eluting stents were used less often in nonagenarians (4.4% versus 16.7%, p < 0.0001). Hospital mortality was significantly much higher in patients over 90 years old (24.9% versus 5.1%, p < 0.001) in univariate analysis. After adjustment for sex, cardiogenic shock, diabetes, triple vessel disease, drug-eluting stent use and glycoprotein IIb/IIIa inhibitors use, mortality remains higher in nonagenarian patients (OR: 4.31; 95% CI: 3.26-5.71, p < 0.0001).
CONCLUSIONS: In a real-world setting, we found important demographic differences in nonagenarian compared to younger patients. Despite achieving a high rate of reperfusion with pPCI using mainly radial access, similar to that achieved in younger patients, hospital mortality was higher in nonagenarians.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Elderly; Myocardial infarction; Nonagenarian; Primary PCI

Mesh:

Year:  2015        PMID: 25985011     DOI: 10.1016/j.ijcard.2015.04.227

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.

Authors:  Peter R Sinnaeve; Thierry Danays; Kris Bogaerts; Frans Van de Werf; Paul W Armstrong
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

2.  Atorvastatin combined with routine therapy on HIF-1, VEGF concentration and cardiac function in rats with acute myocardial infarction.

Authors:  Jingbin Yu; Lei Zhang; Hui Zhang
Journal:  Exp Ther Med       Date:  2020-01-27       Impact factor: 2.447

Review 3.  Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach.

Authors:  Benoit Lattuca; Mathieu Kerneis; Michel Zeitouni; Guillaume Cayla; Paul Guedeney; Jean-Philippe Collet; Gilles Montalescot; Johanne Silvain
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

4.  Managing Nonagenarians with Acute Myocardial Infarction: Invasive versus Conservative Treatment.

Authors:  Jooho Lee; Kyoung-Woo Seo; Jin-Sun Park; Hyoung-Mo Yang; Hong-Seok Lim; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jae Tahk; Joon-Han Shin
Journal:  Cardiol Res Pract       Date:  2020-11-10       Impact factor: 1.866

5.  Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.

Authors:  Thibaut Petroni; Azfar Zaman; Jean-Louis Georges; Nadjib Hammoudi; Emmanuel Berman; Amit Segev; Jean-Michel Juliard; Olivier Barthelemy; Johanne Silvain; Rémi Choussat; Claude Le Feuvre; Gérard Helft
Journal:  Heart       Date:  2016-07-13       Impact factor: 5.994

6.  Outcome of 1051 Octogenarian Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Observational Cohort From the London Heart Attack Group.

Authors:  Daniel I Bromage; Daniel A Jones; Krishnaraj S Rathod; Claire Grout; M Bilal Iqbal; Pitt Lim; Ajay Jain; Sundeep S Kalra; Tom Crake; Zoe Astroulakis; Mick Ozkor; Roby D Rakhit; Charles J Knight; Miles C Dalby; Iqbal S Malik; Anthony Mathur; Simon Redwood; Philip A MacCarthy; Andrew Wragg
Journal:  J Am Heart Assoc       Date:  2016-06-27       Impact factor: 5.501

7.  Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).

Authors:  Yohei Numasawa; Taku Inohara; Hideki Ishii; Kyohei Yamaji; Shun Kohsaka; Mitsuaki Sawano; Masaki Kodaira; Shiro Uemura; Kazushige Kadota; Tetsuya Amano; Masato Nakamura
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

8.  Outcomes of Nonagenarians with Acute Myocardial Infarction with or without Coronary Intervention.

Authors:  Seok Oh; Myung Ho Jeong; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.